August 07, 2018

Amgen Inc. et al v. Accord BioPharma

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. April 05, 2019

    Apotex Can't Sink Amgen's IP Suit Over Drugs To Aid Chemo

    Amgen can move forward with allegations that Apotex infringed a patent covering its chemotherapy-easing drugs Neupogen and Neulasta after a Florida federal judge ruled that it was too early to find the suit was barred by litigation over a related patent.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!